These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 32469607

  • 21. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N, Janga KY.
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [Abstract] [Full Text] [Related]

  • 22. Formulation development and characterization of lumefantrine nanosuspension for enhanced antimalarial activity.
    Shah R, Soni T, Shah U, Suhagia BN, Patel MN, Patel T, Gabr GA, Gorain B, Kesharwani P.
    J Biomater Sci Polym Ed; 2021 May; 32(7):833-857. PubMed ID: 33380264
    [Abstract] [Full Text] [Related]

  • 23. Fabrication of an aprepitant nanosuspension using hydroxypropyl chitosan to increase the bioavailability.
    Liu J, Li S, Ao W, Li Y, Xiao Y, Bai M.
    Biochem Biophys Res Commun; 2022 Nov 26; 631():72-77. PubMed ID: 36179498
    [Abstract] [Full Text] [Related]

  • 24. Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study.
    Gora S, Mustafa G, Sahni JK, Ali J, Baboota S.
    Drug Deliv; 2016 Nov 26; 23(3):940-50. PubMed ID: 24937379
    [Abstract] [Full Text] [Related]

  • 25. Production, Characterization and Evaluation of Kaempferol Nanosuspension for Improving Oral Bioavailability.
    Qian YS, Ramamurthy S, Candasamy M, Shadab M, Kumar RH, Meka VS.
    Curr Pharm Biotechnol; 2016 Nov 26; 17(6):549-55. PubMed ID: 26813303
    [Abstract] [Full Text] [Related]

  • 26. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK, Patel MH, Patel K.
    Drug Dev Ind Pharm; 2016 Nov 26; 42(5):758-68. PubMed ID: 26548349
    [Abstract] [Full Text] [Related]

  • 27. Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies.
    Patel HP, Chaudhari PS, Gandhi PA, Desai BV, Desai DT, Dedhiya PP, Vyas BA, Maulvi FA.
    Int J Pharm; 2021 May 01; 600():120474. PubMed ID: 33737093
    [Abstract] [Full Text] [Related]

  • 28. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells.
    Qiao F, Zhao Y, Mai Y, Guo J, Dong L, Zhang W, Yang J.
    Planta Med; 2020 May 01; 86(8):538-547. PubMed ID: 32294789
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S, Reddy VA, Arora S, Patel K.
    Drug Deliv Transl Res; 2016 Oct 01; 6(5):498-510. PubMed ID: 27129488
    [Abstract] [Full Text] [Related]

  • 32. Development and evaluation of TPGS/PVA-based nanosuspension for enhancing dissolution and oral bioavailability of ticagrelor.
    Na YG, Pham TMA, Byeon JJ, Kim MK, Han MG, Baek JS, Lee HK, Cho CW.
    Int J Pharm; 2020 May 15; 581():119287. PubMed ID: 32243963
    [Abstract] [Full Text] [Related]

  • 33. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
    Zhao J, Luo L, Fu Q, Guo B, Li Y, Geng Y, Wang J, Zhang T.
    Curr Drug Deliv; 2016 May 15; 13(5):764-73. PubMed ID: 25963306
    [Abstract] [Full Text] [Related]

  • 34. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
    Kassem MAA, ElMeshad AN, Fares AR.
    AAPS PharmSciTech; 2017 May 15; 18(4):983-996. PubMed ID: 27506564
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.
    Hanafy A, Spahn-Langguth H, Vergnault G, Grenier P, Tubic Grozdanis M, Lenhardt T, Langguth P.
    Adv Drug Deliv Rev; 2007 Jul 10; 59(6):419-26. PubMed ID: 17566595
    [Abstract] [Full Text] [Related]

  • 36. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation.
    Geng T, Banerjee P, Lu Z, Zoghbi A, Li T, Wang B.
    Eur J Pharm Sci; 2017 Nov 15; 109():200-208. PubMed ID: 28811130
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.